SCHEMBL8739614

SCHEMBL8739614

O=C(CCNCCCN1CCCC1)OCCCCOC(=O)CCN(CCCCCO)CCC(=O)OCCCCOC(=O)CCNCCCN1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 1/20 0.37
SMYD2 Q9NRG4 2/20 0.33
ACHE P22303 6/20 0.33
HRH3 Q9Y5N1 8/20 0.32
HRH4 Q9H3N8 2/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10099917 0.95 PAOX (0.36) PAOXACHE
SCHEMBL8739604 0.95 ACHE (0.39) PAOXACHEHRH3KCNH2
SCHEMBL8738807 0.91 PAOX (0.38) PAOXACHE
SCHEMBL25820446 0.91 PAOX (0.38) PAOXACHE
SCHEMBL19829897 0.90 PAOX (0.37) PAOXACHE
SCHEMBL8739618 0.89 PAOX (0.38) PAOXACHEHRH3
SCHEMBL25820457 0.88 PAOX (0.39) PAOXACHEHRH3
SCHEMBL8739109 0.88 THRA (0.40) PAOXACHE
SCHEMBL26872388 0.88 ACHE (0.36) PAOXACHEHRH3
SCHEMBL8738445 0.86 PAOX (0.38) PAOXHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180177881-A1 Multicomponent Degradable Cationic Polymers THE JOHNS HOPKINS UNIVERSITY 2018-06-28 US disclosed
US-9884118-B2 Multicomponent degradable cationic polymers THE JOHNS HOPKINS UNIVERSITY (US) 2018-02-06 US disclosed
US-20180028455-A1 PEPTIDE/PARTICLE DELIVERY SYSTEMS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-02-01 US disclosed
US-20170143639-A1 NANOCOMPOSITES OF GOLD AND POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2017-05-25 US disclosed
US-20150272900-A1 Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics THE JOHNS HOPKINS UNIVERSITY 2015-10-01 US disclosed
US-20150250881-A1 Multicomponent Degradable Cationic Polymers THE JOHNS HOPKINS UNIVERSITY (US) 2015-09-10 US disclosed
US-20140294909-A1 NANOCOMPOSITES OF GOLD AND POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2014-10-02 US disclosed
US-20120128782-A1 Multicomponent Degradable Cationic Polymers THE JOHNS HOPKINS UNIVERSITY (US) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150272900-A1 Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics DNMT3L, DBNL, HNRNPL PAOX 4804/4885SMYD2 1487/4885ACHE 1104/4885
US-20150250881-A1 Multicomponent Degradable Cationic Polymers PEF1, FIBP, PARN PAOX 1525/4885SMYD2 1791/4885ACHE 4465/4885
US-20180177881-A1 Multicomponent Degradable Cationic Polymers PEF1, FIBP, PARN PAOX 1525/4885SMYD2 1791/4885ACHE 4465/4885
US-20170143639-A1 NANOCOMPOSITES OF GOLD AND POLYMERS HNRNPL, HNRNPLL, ACSL3 PAOX 4172/4885SMYD2 3009/4885ACHE 1213/4885
US-20120128782-A1 Multicomponent Degradable Cationic Polymers PEF1, FIBP, PARN PAOX 1525/4885SMYD2 1791/4885ACHE 4465/4885
US-20180028455-A1 PEPTIDE/PARTICLE DELIVERY SYSTEMS VEGFA, IAPP, FLT1 PAOX 3116/4885SMYD2 4456/4885ACHE 4729/4885
US-20140294909-A1 NANOCOMPOSITES OF GOLD AND POLYMERS HNRNPL, HNRNPLL, ACSL3 PAOX 4172/4885SMYD2 3009/4885ACHE 1213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.